Results 291 to 300 of about 616,613 (359)

N6‐Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential

open access: yesiNew Medicine, EarlyView.
ABSTRACT Accumulating evidence highlights the critical role of epigenetic modifications, particularly N6‐methyladenosine (m6A), in liver disease. As the most abundant RNA modification in eukaryotic cells, m6A is dynamically regulated by multicomponent m6A methyltransferases (e.g., METTL3 and METTL14), demethylases (FTO and ALKBH5), and m6A‐binding ...
Yingfen Chen   +6 more
wiley   +1 more source

Significant histologic alterations in untreated chronic hepatitis B children: a meta-analysis. [PDF]

open access: yesBMC Infect Dis
Huang C   +9 more
europepmc   +1 more source

Assessing Liver Fibrosis in Chronic Hepatitis B: Liver Biopsy or Non-Invasive Fibrosis Markers? [PDF]

open access: yesJ Clin Med
Borcak D   +9 more
europepmc   +1 more source

Elevated serum TIM4 is associated with disease severity and serves as a potential predictive biomarker in chronic hepatitis B. [PDF]

open access: yesBMC Infect Dis
Deng Y   +10 more
europepmc   +1 more source

Unveiling low level viremia in chronic hepatitis B: challenges and new horizons. [PDF]

open access: yesFront Cell Infect Microbiol
Wang B   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy